Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
dc.creator | He, Yundong | |
dc.creator | Peng, Shihong | |
dc.creator | Wang, Jinhua | |
dc.creator | Chen, Huang | |
dc.creator | Cong, Xiaonan | |
dc.creator | Chen, Ang | |
dc.creator | Hu, Meichun | |
dc.creator | Qin, Min | |
dc.creator | Wu, Haigang | |
dc.creator | Gao, Shuman | |
dc.creator | Wang, Liguo | |
dc.creator | Wang, Xin | |
dc.creator | Yi, Zhengfang | |
dc.creator | Liu, Mingyao | |
dc.date.accessioned | 2019-10-08T20:05:09Z | |
dc.date.available | 2019-10-08T20:05:09Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 2041-1723 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/178431 | |
dc.format.extent | 0 | en |
dc.publisher | Nature Communications | |
dc.relation.ispartof | 1foldr Import 2019-10-08 Batch 1 | en |
dc.relation.uri | 10.1038/ncomms13122 | en |
dc.title | Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer | en |